D

AgomAb Therapeutics Series D

Company announces $89m financing with new investors Sanofi and Invus alongside existing investors.

Suggest an update

$89,000,000 AmountOct 25, 2024 Announced

Source evidence

Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-focused Pipeline · agomab01-a405198c5a-abf8c4eyf4e4gace.z02.azurefd.net ↗

Something wrong or missing? Send an update. Fixed within 24 hours.